CBL-B modulators and uses thereof
US12325697B2 · kind B2 · utility
0Cited by
14References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2022 |
| Grant date | Jun 10, 2025 |
| Priority date | — |
| Expiry date | Apr 8, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F5/022
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of Cbl-b, and the treatment of Cbl-b-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.